trial · primary record
TMV Vaccine
Squamous Cell Carcinoma of Head and Neck
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2031-02-28 |
| Primary endpoint | Number of Participants With Dose-Limiting Toxicities (DLTs) in Phase 1a |
| Registry ID | NCT07898124 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:51.512Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07898124
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.